Alogliptin after acute coronary syndrome in patients with type 2 diabetes: a renal function stratified analysis of the EXAMINE trial

Alogliptin after acute coronary syndrome in patients with type 2 diabetes: a renal function stratified analysis of the EXAMINE trial

Abstract Background The EXAMINE trial tested the efficacy and safety of alogliptin, an inhibitor of dipeptidyl peptidase 4, compared with placebo in 5380 patients with type 2 diabetes and a recent acute coronary syndrome. Because alogliptin is cleared by the kidney, patients were stratified accordin...

Full description

Bibliographic Details
Main Authors: João Pedro Ferreira, Cyrus Mehta, Abhinav Sharma, Steven E. Nissen, Patrick Rossignol, Faiez Zannad
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Medicine
Subjects:
Alogliptin
Renal function
Stratification
Outcomes
Online Access:http://link.springer.com/article/10.1186/s12916-020-01616-8

Internet

http://link.springer.com/article/10.1186/s12916-020-01616-8

Similar Items